Author

P. Faridi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Organism:human· 3 Assay:proteomics· 3 Approach:experimental assay· 2 Approach:biophysical modeling· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. W. Purcell· 4 shared S. H. Ramarathinam· 3 shared A. Behren· 2 shared A. Braun· 1 shared A. F. Sharland· 1 shared A. Peng· 1 shared B. Rono· 1 shared C. Deceneux· 1 shared

Activity by Year

2020-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

A. W. Purcell

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Endogenous viral elements constitute a complementary source of antigens for personalized cancer vaccines

C. Garde, M. A. Pavlidis, P. Garces, E. J. Lange, S. H. Ramarathinam, M. Sokac, K. Pandey, P. Faridi, J. Ahrenfeldt, S. Chung, S. Friis, D. Kleine-Kohlbrecher, N. J. Birkbak, J. V. Kringelum, B. Rono, , T. Trolle

This paper identifies endogenous viral elements as a new source of antigens for personalized cancer vaccines and introduces a computational pipeline to predict and test their therapeutic potential.

bioRxiv · Mar 23, 2023Cancer Biology

The self-peptide repertoire plays a critical role in transplant tolerance induction

E. T. Son, P. Faridi, M. Paul-Heng, M. Leong, K. English, S. H. Ramarathinam, A. Braun, N. Dudek, I. E. Alexander, L. Lisowski, P. Bertolino, D. Bowen, A. W. Purcell, N. Mifsud, A. F. Sharland

This study identifies immunogenic MHC I peptides involved in transplant tolerance by combining genetic engineering, immunopeptidomics, and T cell analysis.

bioRxiv · Nov 9, 2020Immunology

A peptide-signal amplification strategy for the detection and validation of neoepitope presentation on cancer biopsies

S. H. Ramarathinam, P. Faridi, A. Peng, P. Szeto, N. C. Wong, A. Behren, M. Shackleton, A. W. Purcell

The paper develops a mass spectrometry-based method to detect HLA-bound peptides from tumor biopsies, enabling the identification of neoepitopes from as few as 1000 cells or 1 mg of tissue.

bioRxiv · Jun 12, 2020 · PreprintImmunology

Spliced peptides and cytokine driven changes in the immunopeptidome of melanoma

P. Faridi, K. Woods, S. Ostrouska, C. Deceneux, S. Q. Wong, W. Chen, R. Aranha, D. Duscharla, N. P. Croft, C. Li, R. Ayala, J. Cebon, A. W. Purcell, R. B. Schittenhelm, A. Behren

This study identifies spliced peptides and cytokine-driven changes in the immunopeptidome of melanoma, showing conserved immunogenic peptides across patients.

bioRxiv · Jun 1, 2020Immunology